OSLER DIAGNOSTICS
LIVE

Serial Number

88923481

Owner

Osler Diagnostics Limited

Attorney

Eric Lamb

Filing Date

May 19, 2020

Add to watchlist:

No watchlists yet
View on USPTO

OSLER DIAGNOSTICS Trademark

Serial Number: 88923481 • Registration: 6982744

OSLER DIAGNOSTICS is a trademark filed by Osler Diagnostics Limited on May 19, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Osler Diagnostics Limited (12 trademarks)

King Charles House,

Entity Type: 99

Trademark Details

Filing Date

May 19, 2020

Registration Date

February 21, 2023

Published for Opposition

December 6, 2022

Goods & Services

Research in the field of education; consultancy, advisory and information services regarding the aforementioned services in the field of education

Scientific apparatus and instruments, namely, hand-held devices in the nature of a research laboratory analyzer for withdrawing and testing blood for research and scientific purposes and parts and fittings therefor; scientific research and laboratory apparatus and instruments, namely, laboratory centrifuges; material testing apparatus and instruments, namely, electronic apparatus being a research laboratory analyzer for identifying and testing pathogens and biomarkers in blood for research, and scientific purposes; apparatus for transmission of communication; monitoring, measuring, signaling and control apparatus and instruments in the nature of research laboratory analyzers for testing blood against a panel of biomarkers for research, and scientific purposes; audiovisual receivers; computer apparatus and instruments, namely, computer hardware and computer peripheral apparatus; recorded computer software for analyzing data obtained from blood samples; downloadable computer software for analyzing data obtained from blood samples; downloadable application software for analyzing data obtained from blood samples; computer hardware for data capture, collection, recording, processing, transmission, reproduction, storage and communications; electrical parts being electronic components for computers; and replacement parts therefor

Pharmaceuticals for treating viruses, infections, infectious diseases, and skin disorders; medical preparations for treating viruses, infections, infectious diseases, and skin disorders; chemical preparations and reagents for medical purposes for treating viruses, infections, infectious diseases, and skin disorders; diagnostic preparations, substances, agents, reagents, assays and materials for medical purposes; diagnostic testing preparations, substances, agents, reagents, assays and materials for medical purposes, namely, for testing blood and body fluids

Assays and reagents for scientific or medical research purposes

Medical services; medical testing for diagnostic purposes; medical testing, medical screening and medical analysis services relating to the diagnosis of disease; medical testing, medical screening and medical analysis services relating to the treatment of disease; consultancy, advisory and information services regarding the aforementioned services

Medical apparatus and instruments for use in obtaining blood samples; medical apparatus and instruments for diagnostic use in analyzing body fluids; medical apparatus and instruments for identifying pathogens and biomarkers from blood samples; diagnostic testing apparatus and instruments for the measurement of clinical biomarkers; and replacement parts therefor

Product research and development services; medical testing research and development services; scientific medical testing research and development services; pharmaceutical research and development services; new product design services; research, design and development of medical apparatus and instrument products; research, design and development of medical diagnostic apparatus and instruments products; research, design and development of diagnostic test products for the measurement of clinical biomarkers; computer software research, design and development services; consultancy, advisory and information services regarding the aforementioned services

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 8, 2023 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Sep 8, 2023 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 8, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 8, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 28, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 28, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 28, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 28, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 28, 2023 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 21, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 21, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 6, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 6, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 16, 2022 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 25, 2022 PBCR
CASE RETURNED TO EXAMINATION
Oct 7, 2022 OTHE
NOTICE OF ALLOWANCE CANCELLED
Oct 7, 2022 IUCN
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Oct 7, 2022 PCBG
ASSIGNED TO PETITION STAFF
Oct 5, 2022 APET
TEAS PETITION TO AMEND BASIS RECEIVED
Sep 9, 2022 TPAD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 14, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jul 12, 2022 EX2G
SOU EXTENSION 2 FILED
Jul 12, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 12, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jan 11, 2022 EX1G
SOU EXTENSION 1 FILED
Jan 11, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 11, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 20, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 25, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 25, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 5, 2021 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 13, 2021 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 30, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 30, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 30, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 30, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 30, 2021 CNEA
EXAMINER'S AMENDMENT ENTERED
Mar 26, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 26, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 26, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 26, 2021 CNEA
ASSIGNED TO EXAMINER
Mar 1, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 25, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 25, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 25, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 18, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2020 NWOS
NEW APPLICATION ENTERED
May 22, 2020 NWAP